Clinical Trials Browser

Phase 1 × Multiple Myeloma × lucatumumab × Clear all

NCT00231166 2018-10-11

Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma

Phase 1 Completed

Multiple Myeloma